Black Diamond Therapeutics CEO David Epstein's 2022 pay falls 68% to $1.6M
Black Diamond Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 4, 2023
Black Diamond Therapeutics reported fiscal year 2022 executive compensation information on April 4, 2023.
In 2022, three executives at Black Diamond Therapeutics received on average a compensation package of $1.2M, a 57% decrease compared to previous year.
Average pay of disclosed executives at Black Diamond Therapeutics
David M. Epstein, Chief Executive Officer, received $1.6M in total, which decreased by 68% compared to 2021. 46% of Epstein's compensation, or $760K, was in option awards. Epstein also received $310K in non-equity incentive plan, $554K in salary, as well as $20K in other compensation.
Brent Hatzis-Schoch, Chief Operating Officer, received a compensation package of $911K, which decreased by 55% compared to previous year. 50% of the compensation package, or $452K, was in salary.
Fang Ni, Chief Financial Officer, earned $910K in 2022, a 46% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 4, 2023.